BSEIndia
      Close  
NOTICES
Notice No.   20240906-8   Notice Date   06 Sep 2024
Category   Trading   Segment   Equity
Subject   Opening of Offer to Buy – Acquisition Window (Buyback) forANGLO-FRENCH DRUGS & INDUSTRIES LIMITED
Attachments   Letter of Offer.pdf ;
Content

 Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeover, Buy Back and De-listing vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015, and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017, 20190424-35 dated April 24, 2019, and 20200528-32 dated 28 May 2020, 20201102-43 dated Nov 02, 2020, and 20210825-62 dated Aug 25,2021 has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.

 

All Market Participants are hereby informed that ANGLO-FRENCH DRUGS & INDUSTRIES LIMITED (“The Company”) Offer to Buyback up to 1,06,500 (One Lakh Six Thousand Five Hundred) Fully Paid-up equity shares of having face value of Rs.10 /- (Indian Rupees Ten Only) each of the company (“equity shares”), at a price of Rs. 4,000/- (Rupees Four Thousand Only) ("Buy-Back price") per equity share, payable in cash, for an aggregate amount not exceeding Rs. 42,60,00,000/- (Rupees Forty-Two Crore Sixty Lakh Only) (“Buy-Back offer size”) excluding transaction cost, from the equity shareholders / beneficial owners of the equity shares of the company as on the record date Tuesday, September 3, 2024, on a proportionate basis through tender offer route using the stock exchange mechanism (“buy-back”) From Monday, September 09, 2024, to Friday, September 13, 2024.

 

Letter of Offer is herewith attached for perusal.

 

The Company is only listed on Metropolitan Stock Exchange

 

Market participants are further requested to note that this offer will be as per the SEBI circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and SEBI circular no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016 and Exchange notice no. 20170210-16 dated Feb 10, 2017,  20190424-35 dated April 24, 2019 and 20200528-32 dated 28 May 2020 and  the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.

 

 

Mangesh Tayde

Deputy General Manager

Listing Business Relationship

September 06, 2024